Historique de carrière de Benito Munoz
Anciens postes connus de Benito Munoz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/02/2009 | 01/11/2013 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/10/1999 | 01/10/2008 |
| KARYOPHARM THERAPEUTICS INC. | Directeur/Membre du Conseil | - | - |
| PROTEOSTASIS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/03/2017 | - |
| Corporate Officer/Principal | 01/01/2013 | 01/03/2017 |
Formation de Benito Munoz
| University of Toronto | Doctorate Degree |
| Brock University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 3 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Benito Munoz
- Expérience
